Medicare Premiums Increase in 2026
The Centers for Medicare & Medicaid Services (CMS) has just rolled out the latest adjustments for Medicare Parts A and B, effective January 1, 2026. If you’re enrolled in Medicare
The Latest on Canada-US Tariffs
The U.S. suspension of the duty-free “de minimis” threshold for low-value shipments, which took effect on August 29, 2025, continues to reshape cross-border shopping from Canada.
Health Systems Brace for Medicaid Cuts
Hospitals, health systems, and physician practices are recalibrating their operational and financial strategies to navigate evolving federal regulations, according to a recent KLAS Research survey.
Helping Patients Navigate Medicaid Cuts
Recent federal budget cuts signed into law by President Donald Trump are set to impact healthcare access significantly. Over the next decade, the Congressional Budget Office projects that approximately 12
US Employers Shift Benefits Costs
A 2025 Mercer survey of over 500 large U.S. employers (500+ employees) indicates significant changes in employee benefits for 2026, with a focus on cost management and innovative healthcare solutions.
Novo Nordisk’s Patent Lapse Opens Door For Generics
Hims & Hers Health, a U.S.-based telehealth platform, plans to enter the Canadian market in 2026, offering generic semaglutide drugs following the expiration of Novo
Twice-Yearly HIV Shot Gets FDA Greenlight
The U.S. Food and Drug Administration has approved a groundbreaking twice-yearly injection called Yeztugo (lenacapavir) for HIV prevention, developed by Gilead Sciences.
Medicaid Reforms Pass House in Budget Bill
On May 22, 2025, the House of Representatives passed H.R. 119, the “One Big Beautiful Bill Act,” in a razor-thin 215-214 vote, with only Republican support. Championed by President Donald
The Top 10 Best-Selling Drugs in the US
The pharmaceutical industry continues to evolve, bringing innovative treatments to millions of Americans while driving significant economic growth. In 2024, the top-selling prescription drugs in the US
Januvia’s Price Drop Exposes the PBM Profit Game
In a twist that defies logic for many patients, Merck, the pharmaceutical giant behind the blockbuster diabetes drug Januvia (sitagliptin), slashed its price dramatically in early 2025.
Healthcare Costs Unraveled: A Literacy Blueprint for Savings
In an increasingly complex and expensive healthcare landscape, the ability to navigate medical costs has become a critical skill for individuals and families.
Drug Price Reforms Ahead?
The high cost of prescription drugs remains a pressing concern for Americans, with many finding prices unreasonable. A survey by KFF revealed that while 65% of adults find it relatively
Affordable Access to Medications
Prescription medications are essential for managing various health conditions, from chronic illnesses like diabetes and hypertension to acute infections and injuries. However, rising medication costs have become a pressing issue
The 10 Most Prescribed Medications in America
Prescription medications play a vital role in the management and treatment of various health conditions, from chronic diseases like hypertension and diabetes to acute infections and respiratory issues. The landscape
The Cholesterol-Lowering Drug Helping Millions
Atorvastatin, commonly known by the brand name Lipitor, is one of the most prescribed medications worldwide for managing high cholesterol. Belonging to the statin class of drugs, it helps reduce